medigraphic.com
Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán

2002, Number 3

<< Back Next >>

Rev Biomed 2002; 13 (3)

Evidence guide for the treatment of bronchiolitis

Lara-Pérez EA

Language: Spanish
References: 34
Page: 211-219
PDF size: 35.22 Kb.


ABSTRACT

Introduction. Despite de high prevalence of bronchiolitis as an infectious disease, until this moment there is no specific treatment. Nowadays there has been a lot of dispute about the treatment of bronchiolitis because of the quantity of recommendations; on one side; the “classic” therapies and on another the novel therapies, both therapies result to be polemic when they have been scientifically analyzed.
Objective. To evaluate based on a guide; the classic or common therapeutic and the actual therapy of bronchiolitis with demonstrable and credible foundations.
Material and Method. Diagnostic concept of bronchiolitis and bibliography; score evaluation, Evidence level, work evaluation and recommendation.
Results. Bibliographic evaluation charts of the works and recommendations about the known treatments are integrated.
Discussion. despite the commoness of some bronchiolitis treatments in the pediatric services, these treatments lack or are limited in the degree of scientific demonstration of evaluating a benefit. Some popular treatments within the bronchiolitis treatment, have a lack of scientific evidence, unlike other therapies which are automatically ruled out, but it has not been proved that neither of these ones are not useful. It is recommended to realize random studies that offer a better scientific support.


REFERENCES

  1. Everard ML. Bronchiolitis. Origins and optimal management. Drugs. 1995;49:885-96.

  2. Sitio web: Centres for Health Evidence.net en: .

  3. Pilar-Orive FJ, Casado-Flores J, García-Teresa MA. Infecciones respiratorias agudas en Unidades de Cuidados Intensivos Pediátricos. Estudio prospectivo multicéntrico. An Esp Pediatr 1998; 48:138-42.

  4. Kimpen JL, Schaad UB. Treatment of respiratory syncytial virus bronchiolitis: 1995 poll of members of European Society for Paediatric Infections Disease. Pediatr Infect Dis J 1997; 16:479-81.

  5. Lugo RA, Nahata M. Pathogenesis and treatment of bronchiolitis. Clin Pharm 1993; 12:95-116.

  6. Makela MJ, Ruuskanen O, Ogra PL. Treatment of respiratory syncytial virus infections in children. Ann Med 1994; 26:341-3.

  7. Webb MS, Martin JA, Cartlidge PH, Ng YK, Wright NA. Chest physiotherapy in acute bronchiolitis. Arch Dis Child 1985; 60:1078-9.

  8. Kellner VG, Rodríguez W, Kim HW. Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children. Antimicrob Agents Chemother 1987; 31:1882-6.

  9. Flores G, Horwitz RI. Efficacy of beta 2-agonist in bronchiolitis: A reappraisal and meta-analysis. Pediatrics 1997; 100:233-9.

  10. Gadomsky AM, Lichenstein R, Horton L, King J, Keane V, Permutt T. Efficacy of albuterol in the management of bronchiolitis. Pediatrics 1994; 93:907-12.

  11. Ho L, Collins G, Landau LI, Le Souef P. Effect of salbutamol on oxygen saturation in bronchiolitis. Arch Dis Child 1991; 66:1061-4.

  12. Lugo RA, Salyer JW, Dean JM. Albuterol in acute bronchiolitis continued therapy despite poor response? Pharmocotherapy 1998: 198-202.

  13. Menon K, Sutcliffe T, Klasen TP. A randomized trial comparing the efficacy of epinephrine with salbutamol in the treatment for bronchiolitis. J Pediatr 1991; 126:1004-7.

  14. Lodrup-Carlsen KC, Carlsen KH. Inhaled nebulized adrenaline improves lung function in infants with acute bronchiolitis. Respir Med 2000; 94:709-14.

  15. Sammartino LP, Lines D. Efficacy of ipratropium bromide by metered dose aerosol and aerochamber in acute paediatric bronchiolitis. J Paediatr Child Health 1997; 33:459.

  16. Everard ML, Bara A, Kurian M. Anticholinergic drugs for wheeze in children under the age of two years (Cochrane Review). En: The Cochrane Library, Issue 1, Oxford: Update Software; 2001.

  17. Richter H, Seddon P. Early nebulized budesonide in the treatment of Bronchiolitis and the prevention of postbronchiolitic wheezing. J Pediatr 1998; 132: 849-53.

  18. Bulow SM, Nir M, Levin E. Prednisolone treatment for respiratory syncytial virus infection: a randomized controlled trial of 147 infants. Pediatrics 1999; 104:77.

  19. Garrison MM, Christakis DA, Harvey E, Cummins P, Davis RL. Systemic corticosteroids in infant bronchiolitis: A meta-analysis. Pediatrics 2000; 105:849.

  20. Henderson M, Rubin E. Misuse of antimicrobials in children with asthma and bronchiolitis. Pediatr Infect Dis J 2001; 20:214-5.

  21. Früs B, Andersen P, Brenöe E. Antibiotic treatment of pneumonia and Bronchiolitis: a prospective randomized study. Arch Dis Child 1984; 59:2038-45.

  22. Hall CB, Powell KR, Schnabel KC. Risk of secondary bacterial infection in infants hospitalized with RSV infection. J Pediatr 1998; 113:266-71.

  23. Randolph AG, Wang EEL. Ribavirin for respiratory syncytial virus lower respiratory tract infection. In: The Cochrane Library, Issue 1. Oxford: Update Software; 2000.

  24. Guerguerian AM, Gauthier M, Lebel MH, Farrell CA, Lacroix J. Ribavirin in ventilated respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 1999; 160:829-34.

  25. Edell D, Bruce E, Hale K, Khoshoo V. Reduced Longterm respiratory morbidity after treatment of respiratory syncytial virus bronchiolitis with Ribavirin in previously healthy infants: a preliminary report. Pediatr Pulmunology 1998; 25:154-8.

  26. Hollman G, Shen G, Zeng L. Helium-oxygen improves clinical asthma scores in children with acute bronchiolitis. Crit Care Med 1998; 26:1731-6.

  27. Wang EEL, Tang NK. Immunoglobulin for preventing respiratory syncytial virus infection (Cochrane Review): In: The Cochrane Library, Issue 1. Oxford: Update Software; 2001.

  28. Hemming VG, Rodriguez W, Kim HW. Intravenous immunoglobulin treatment of respiratory syncytial virus infection in infants and young children. Antimicrob Agents Chemother 1987; 31:1882-6.

  29. Rodriguez WJ, Gruber WC, Groothuis JR. Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children. Pediatrics 1997; 100:937-42.

  30. Malley R, DeVincenzo J, Ramilo O. Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein. J Infect Dis 1998; 178:1555-61.

  31. Kjolhede CL, Chew FJ, Gadonsky AM, Marroquin DP. Clinical trial of vitamin A as adjuvant treatment for lower respiratory tract infections. J Pediatr 1995; 126: 807-12.

  32. Liu C, Douglas RM. Chinese herbal medicines in the treatment of acute respiratory infections: a review of randomized controlled clinical trials. Med J Aust 1998; 169:579-82.

  33. Chipps BE, Sullivan WF, Portnoy JM. Alpha-2a interferon for treatment of bronchiolitis caused by respiratory syncytial virus. Pediatr Infect Dis J 1993; 12: 653-8.

  34. Labbe A, Billet P, Paire M, Storme B. Treatment of acute bronchiolitis in infants by oral suspensión theophylline. Double-blind study in 62 children. Pediatrics 1985; 40:195-9.




2020     |     www.medigraphic.com